"The Endocrine Society thanks the Subcommittee for the opportunity to submit the following testimony regarding Fiscal Year (FY) 2023 federal appropriations for biomedical research and public health programs. The Endocrine Society is the world's oldest and largest professional organization of endocrinologists representing approximately 18,000 members worldwide. The Society’s membership includes basic and clinical scientists who receive support from the National Institutes of Health (NIH) for research on endocrine diseases that affect millions of Americans, such as diabetes, thyroid disorders, cancer, infertility, aging, obesity and bone disease. Our membership also includes clinicians who depend on new scientific advances to better treat and cure these diseases. We are dedicated to promoting excellence in research, education, and clinical practice in the field of endocrinology. To support necessary advances in biomedical research to improve health, the Endocrine Society recommends the NIH receive funding of at least $50 billion for fiscal year (FY) 2023; to facilitate the translation of these advances to improve public health, the Endocrine Society recommends the CDC receive funding of at least $11 billion; and to ensure that women have access to appropriate health services, we recommend that the Title X program be funded at $737 million. This request does not include additional emergency supplemental funds or new programs situated in NIH including the Advanced Research Projects Agency for Health (ARPA-H)."
Read the Full Testimony
We rely on your voice to advocate for our policy priorities. Join us to show our strength as a community that cares about endocrinology. Contact your U.S representatives or European Members of Parliament through our online platform. Take action and make a difference today.